Zomedica Pharmaceuticals Corp. (ZOM) has 44 open-market insider trades by 13 insiders since 2018. The most active filer is Johnny D. Powers, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Robert Cohen | CEO | — | 2 | $3.0M | 2021-06-30 |
| Johnny D. Powers | Dir | — | 16 | $989K | 2025-03-17 |
| Stephanie Morley | PresCMO | — | 1 | $934K | 2021-04-12 |
| James LeBar | Dir | — | 1 | $430K | 2018-08-28 |
| Russell Kevin Klass | PresVP | — | 4 | $262K | 2025-03-17 |
| Jeffrey M. Rowe | Dir | — | 1 | $147K | 2025-03-17 |
| Larry C. Heaton II | CEO | — | 6 | $105K | 2025-03-17 |
| Anthony K. Blair | COO | — | 4 | $83K | 2025-03-17 |
| Scott Jordan | CFO | — | 1 | $18K | 2025-03-17 |
| Rodney James Williams | Dir | — | 4 | $17K | 2025-03-17 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Rodney James Williams | Director | Buy | $7K | 2025-03-17 |
| Anthony K. Blair | COO | Buy | $30K | 2025-03-17 |
| Larry C. Heaton II | CEO | Buy | $30K | 2025-03-17 |
| Johnny D. Powers | Director | Buy | $11K | 2025-03-17 |
| Russell Kevin Klass | President & VP | Buy | $49K | 2025-03-17 |
| Jeffrey M. Rowe | Director | Buy | $147K | 2025-03-17 |
Companies that share insiders with ZOM, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Scott Jordan | CFO | Buy | $18K | 2025-03-17 |
| Christopher Ross MacLeod | Director | Buy | $9K | 2025-03-17 |
| Johnny D. Powers | Director | Buy | $12K | 2024-11-11 |
| Russell Kevin Klass | President & VP | Buy | $60K | 2024-11-11 |
| Anthony K. Blair | COO | Buy | $18K | 2024-11-08 |
| Larry C. Heaton II | CEO | Buy | $13K | 2024-09-05 |
| Johnny D. Powers | Director | Buy | $13K | 2024-08-28 |
| Anthony K. Blair | COO | Buy | $14K | 2024-08-20 |
| Russell Kevin Klass | President & VP | Buy | $48K | 2024-06-12 |